Function of ssDNA aptamer and aptamer pool against Mycobacterium tuberculosis in a mouse model

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 669-673

  Chen, Fan ^a,b   Zhou, Jing ^c   Huang, Yong Hao ^b   Huang, Feng Ying ^b   Liu, Qiang ^b   Fang, Zhigang ^b   Yang, Sheng ^a   Xiong, Min ^a   Lin, Ying Ying ^b   Tan, Guang Hong ^b  

^a HUBEI UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c Wuhan Tuberculosis Dispensary   (China)

Author keywords

Mouse model; Mycobacterium tuberculosis; SsDNA aptamer

Indexed keywords

APTAMER; GAMMA INTERFERON; NK2 APTAMER; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LUNG ALVEOLUS; LUNG BIOPSY; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE BINDING SITE; PATHOGENICITY; PERITONEUM MACROPHAGE;

ANIMALS; APTAMERS, NUCLEOTIDE; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DNA, SINGLE-STRANDED; INTERFERON-GAMMA; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SELEX APTAMER TECHNIQUE;

EID: 84873864932     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1229     Document Type: Article

References (20)

1. Raviglione MC, Dye C, Schmidt S and Kochi A: Assessment of worldwide tuberculosis control. WHO global surveillance and monitoring project. Lancet 350: 624-649, 1997.
2. Dye C, Scheele S, Dolin P, Pathania V and Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686, 1999.
3. Fine PE: Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345, 1995.
4. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P and Nunn P: Global surveillance for antituberculosis-drug resistance 1994-1997. World Health Organization-International Union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance. N Engl J Med 338: 1641-1649, 1998.
5. Ahmed N and Hasnain SE: Genomics of Mycobacterium tuberculosis: old threats and new trends. Indian J Med Res 120: 207-212, 2004.
6. Baptista IMFD, Oelemann MC, Opromolla DVA and Suffys PA: Drug resistance and genotypes of strains of Mycobacterium tuberculosis isolated from human immunodeficiency virus-infected and non-infected tuberculosis patients in Bauru, São Paulo, Brazil. Mem Inst Oswaldo Cruz: 97: 1147-1152, 2002.
7. Pereira M, Tripathy S, Inamdar V, Ramesh K, Bhavsar M, Date A, Iyyer R, Acchammachary A, Mehendale S and Risbud A: Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res 121: 235-239, 2005.
8. Yew WW and Leung CC: Update in tuberculosis 2007. Am J Respir Crit Care Med 177: 479-485, 2008.
9. Jayasena SD: Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45: 1628-1650, 1999.
10. Guthrie JW, Hamula CLA, Zhang H and Le XC: Assays for cytokines using aptamers. Methods 38: 324-330, 2006.
11. Ulrich H, Alves MJM and Colli W: RNA and DNA aptamers as potential tools to prevent cell adhesion in disease. Braz J Med Bio 34: 295-300, 2001.
12. Marimuthu C, Tang TH, Tominaga J, Tan SC and Gopinath SC: Single-stranded DNA (ssDNA) production in DNA aptamer generation. Analyst 137: 1307-1315, 2012.
13. Shimada T, Fujita N, Maeda M and Ishihama A: Systematic search for the Cra-binding promoters using genomic SELEX system. Genes Cells 10: 907-918, 2005.
14. Jensen KB, Atkinson BL, Willis MC, Koch TD and Gold L: Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA 92: 12220-12224, 1995.
15. Chen F, Zhou J, Luo F, Mohammed AB and Zhang ZL: Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun 357: 743-748, 2007.
16. Chen F, Zhang XL, Zhou J, Liu S and Liu J: Aptamer inhibits Mycobacterium tuberculosis (H37Rv) invasion of macrophage. Mol Biol Rep 39: 2157-2162, 2012.
17. Jagannath C, Emanuele MH and Hunter RL: Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice. Intern J Anti Agent 15: 55-63, 2000.
18. Jing N and Hogan ME: Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug. J Biol Chem 273: 34992-34999, 1998.
19. Blank M, Weinschenk T, Priemer M and Schluesener H: Systematic evolution of a DNA aptamer binding to the rat brain tumor microvessels: selective targeting of endothelial regulatory protein pigpen. J Biol Chem 276: 16464-16468, 2001.
20. Cerchia L, Ducongé F, Pestourie C, Boulay J, Aissouni Y, Gombert K, Tavitian B, de Franciscis V and Libri D: Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 3: e123, 2005.